Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?

To: Pete Mason who wrote (4066)	11/8/1999 11:53:00 AM
From: DanZ	Read Replies (1) \| Respond to of 19428

Pete, Here's the run down on the market makers that you mentioned, NITE, GRUN, MASH, FCAP, HRZG, CRUT, and WEDB. NITE, GRUN, MASH, and HRZG are very large and trade nearly every stock on Nasdaq. Of course they trade CSCC and GUMM, along with thousands of other stocks. The other market makers, FCAP, CRUT, and WEDB are all small and haven't traded a single share of GUMM this year that I can find. NITE = Knight/Trimark, by far the biggest Nasdaq market maker of all. GRUN = Gruntal...That name stands on its own MASH = Mayer & Schweitzer, one of the biggest wholesalers making a market in nearly every Nasdaq stock. They are owned by Charles Schwab and have traded over 15 billion shares so far this year. FCAP = First Union Capital Markets Corporation. I know very little about them and I haven't seen them trade a single share of GUMM. HRZG = Herzog, Heine, Geduld, another big wholesaler. They have traded over 9 billion shares so far this year and make a market in nearly every Nasdaq stock CRUT = Cruttenden Roth Inc. I know nothing about them, they are tiny, and haven't traded a single share of GUMM that I can find. WEDB = Wedbush Morgan Securities, another tiny market maker with only 164 million shares traded so far this year, none of which are in GUMM that I can find. You can see the market makers that trade GUMM at nasdaqtrader.com <Is there anything to be made from this info, or is it mostly meaningless??> You asked an interesting question, but the answer is that there is no correlation between the market makers who trade GUMM and what you hope will happen to the stock. At this time, before the results of the second clinical studies are announced, GUMM is one of the dumbest and riskiest shorts that I have ever witnessed. The risk to reward is so bad that I can't imagine any rational person shorting the stock. Luck, Dan